Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat.: Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release

被引:36
作者
de la Mora, Miguel Perez [1 ]
Hernandez-Gomez, Ana Maria [1 ]
Arizmendi-Garcia, Yexel [1 ]
Jacobsen, Kirsten X. [2 ]
Lara-Garcia, Daniel [1 ]
Flores-Gracia, Candy [1 ]
Crespo-Ramirez, Minerva [1 ]
Gallegos-Cari, Andrea [1 ]
Nuche-Bricaire, Avril [1 ]
Fuxe, Kiell [3 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biophys, Mexico City 04510, DF, Mexico
[2] Univ Ottawa, Neurosci Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada
[3] Karolinska Inst, Dept Neurosci, Stockholm 17177, Sweden
关键词
amygdala; basolateral amygdaloid nucleus; glutamate; intercalated islands;
D O I
10.1111/j.1460-9568.2007.05963.x
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The amygdala plays a key role in fear and anxiety. The intercalated islands are clusters of glutamate-responsive GABAergic neurons rich in cholecystokinin (CCK)-2 receptors which control the trafficking of nerve impulses from the cerebral cortex to the central nucleus of amygdala. In this study, the nature of the CCK-glutamate-GABA interactions within the rat rostral amygdala, and their relevance for anxiety, were studied. CCK/gastrin-like immunoreactive nerve terminals were found to be mainly restricted to the paracapsular intercalated islands and the rostrolateral part of the main intercalated island. Behaviourally, the bilateral microinjection of CCK-4 (0.043-4.3 pmol/side) or CCK-8S (4.3 pmol/side) into the rostrolateral amygdala reduced the open-arm exploration in the elevated plus-maze without affecting locomotion. In contrast, neither CCK-4 nor CCK-8S (0.043-4.3 pmol/side) had any effects in the shock-probe burying test as compared with their saline-treated controls. Biochemically, CCK-4 (0.3 and 1.5 mu M), unlike CCK-8S, enhanced significantly the K+-stimulated release of [H-3]GABA from amygdala slices. These effects were fully prevented by prior superfusion of the slices with either the selective CCK-2 receptor antagonist CR2945 (3 mu M), or 6,7-dinitroquinoxaline-2,3(1H,4H)-dione (DNQX), 10 mu M, a glutamatergic (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptor antagonist. It is suggested that CCK modulates glutamate-GABA mechanisms by acting on CCK-2 receptors via volume transmission occurring at the level of the basolateral amygdaloid nucleus and/or by synaptic or perisynaptic volume transmission in the region of the rostrolateral main and paracapsular intercalated islands, resulting in subsequent disinhibition of the central amygdaloid nucleus and anxiety or panic-like behaviour.
引用
收藏
页码:3614 / 3630
页数:17
相关论文
共 96 条
[1]
Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases [J].
Agnati, LF ;
Ferre, S ;
Burioni, R ;
Woods, A ;
Genedani, S ;
Franco, R ;
Fuxe, K .
NEUROMOLECULAR MEDICINE, 2005, 7 (1-2) :61-78
[2]
A CORRELATION-ANALYSIS OF THE REGIONAL DISTRIBUTION OF CENTRAL ENKEPHALIN AND BETA-ENDORPHIN IMMUNOREACTIVE TERMINALS AND OF OPIATE RECEPTORS IN ADULT AND OLD MALE-RATS - EVIDENCE FOR THE EXISTENCE OF 2 MAIN TYPES OF COMMUNICATION IN THE CENTRAL-NERVOUS-SYSTEM - THE VOLUME TRANSMISSION AND THE WIRING TRANSMISSIOI [J].
AGNATI, LF ;
FUXE, K ;
ZOLI, M ;
OZINI, I ;
TOFFANO, G ;
FERRAGUTI, F .
ACTA PHYSIOLOGICA SCANDINAVICA, 1986, 128 (02) :201-207
[3]
[Anonymous], 1991, Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission
[4]
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats [J].
Basso, AM ;
Spina, M ;
Rivier, J ;
Vale, W ;
Koob, GF .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :21-30
[5]
ANTIPANIC DRUG TREATMENTS - FAILURE TO EXHIBIT ANXIOLYTIC-LIKE EFFECTS ON DEFENSIVE BURYING BEHAVIOR [J].
BEARDSLEE, SL ;
PAPADAKIS, E ;
FONTANA, DJ ;
COMMISSARIS, RL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) :451-455
[6]
Beinfeld Margery C., 1995, P585
[7]
ASYMMETRY IN BEHAVIORAL-RESPONSES TO CHOLECYSTOKININ MICROINJECTED INTO RAT NUCLEUS-ACCUMBENS AND AMYGDALA [J].
BELCHEVA, I ;
BELCHEVA, S ;
PETKOV, VV ;
PETKOV, VD .
NEUROPHARMACOLOGY, 1994, 33 (08) :995-1002
[8]
GABA, ACTING AT BOTH GABA(A) AND GABA(B) RECEPTORS, INHIBITS THE RELEASE OF CHOLECYSTOKININ-LIKE MATERIAL FROM THE RAT SPINAL-CORD INVITRO [J].
BENOLIEL, JJ ;
BOURGOIN, S ;
MAUBORGNE, A ;
POHL, M ;
LEGRAND, JC ;
HAMON, M ;
CESSELIN, F .
BRAIN RESEARCH, 1992, 590 (1-2) :255-262
[9]
COMBINED DOSE-RATIO ANALYSIS OF CHOLECYSTOKININ RECEPTOR ANTAGONISTS, DEVAZEPIDE, LORGLUMIDE AND LOXIGLUMIDE IN THE GUINEA-PIG GALL-BLADDER [J].
BISHOP, LA ;
GERSKOWITCH, VP ;
HULL, RAD ;
SHANKLEY, NP ;
BLACK, JW .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (01) :61-66
[10]
Cholecystokinin and panic disorder: Past and future clinical research strategies [J].
Bradwejn, J ;
Koszycki, D .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2001, 61 :19-27